Cargando…

Mitochondrial Quality Control in Hepatocellular Carcinoma

Mitochondria participate in the progression of hepatocellular carcinoma (HCC) by modifying processes including but not limited to redox homeostasis, metabolism, and the cell death pathway. These processes depend on the health status of the mitochondria. Quality control processes in mitochondria can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bian, Jinda, Zhang, Dan, Wang, Yicun, Qin, Hanjiao, Yang, Wei, Cui, Ranji, Sheng, Jiyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473831/ https://www.ncbi.nlm.nih.gov/pubmed/34589426 http://dx.doi.org/10.3389/fonc.2021.713721

Ejemplares similares

Advances in Renal Cell Carcinoma Drug Resistance Models
por: Xiang, Yien, et al.
Publicado: (2022)

Precision diagnosis of hepatocellular carcinoma
por: Wang, Zhenxiao, et al.
Publicado: (2023)

The Application Progress of Patient-Derived Tumor Xenograft Models After Cholangiocarcinoma Surgeries
por: Wu, Jun, et al.
Publicado: (2021)

Inhibition of PI3K/mTOR increased the sensitivity of hepatocellular carcinoma cells to cisplatin via interference with mitochondrial‐lysosomal crosstalk
por: Sheng, Jiyao, et al.
Publicado: (2019)

The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain
por: Sheng, Jiyao, et al.
Publicado: (2017)

Filamentous Bacteriophage—A Powerful Carrier for Glioma Therapy
por: Wang, Yicun, et al.
Publicado: (2021)

Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
por: Zhang, Chaohe, et al.
Publicado: (2020)

The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment
por: Qin, Hanjiao, et al.
Publicado: (2018)

Astragaloside in cancer chemoprevention and therapy
por: Wang, Yaning, et al.
Publicado: (2023)

Drug-Resistant Epilepsy and Surgery
por: Sheng, Jiyao, et al.
Publicado: (2018)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma
por: Yang, Jin-Cui, et al.
Publicado: (2022)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

An Efficient Nomogram for Discriminating Intrahepatic Cholangiocarcinoma From Hepatocellular Carcinoma: A Retrospective Study
por: Si, Yuan-Quan, et al.
Publicado: (2022)

Scutellaria barbata Inhibits Hepatocellular Carcinoma Tumorigenicity by Inducing Ferroptosis of Hepatocellular Carcinoma Cells
por: Li, Yue, et al.
Publicado: (2022)

Ketogenic Diets and Hepatocellular Carcinoma
por: Lan, Yan, et al.
Publicado: (2022)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

A Correlative Study Between IVIM-DWI Parameters and the Expression Levels of Ang-2 and TKT in Hepatocellular Carcinoma
por: Zheng, Jing, et al.
Publicado: (2021)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

Gut microbiota changes and biological mechanism in hepatocellular carcinoma after transarterial chemoembolization treatment
por: Bian, Chao-fan, et al.
Publicado: (2022)

Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges
por: Wang, Juan, et al.
Publicado: (2022)

Corrigendum: Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2022)

The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

Comparison of NK cell subsets, receptors and functions induced by radiofrequency ablation and microwave ablation in HBV-associated primary hepatocellular carcinoma
por: Wang, Hai-Yan, et al.
Publicado: (2023)

Unresectable Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Combined With Microwave Ablation vs. Combined With Cryoablation
por: Wei, Jialiang, et al.
Publicado: (2020)

Four circadian rhythm-related genes predict incidence and prognosis in hepatocellular carcinoma
por: Wu, Zhenyu, et al.
Publicado: (2022)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Targeting mitochondrial quality control of T cells: Regulating the immune response in HCC
por: Xia, Yixue, et al.
Publicado: (2022)

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Tiantian, et al.
Publicado: (2022)

Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report
por: Deng, Yuan, et al.
Publicado: (2021)

Neural Mechanisms With Respect to Different Paradigms and Relevant Regulatory Factors in Empathy for Pain
por: Xiang, Yien, et al.
Publicado: (2018)

Photodynamic and Photothermal Therapy of Hepatocellular Carcinoma
por: Fan, Zhe, et al.
Publicado: (2021)

Recent Advances in Herbal Medicines for Digestive System Malignancies
por: Sheng, Jiyao, et al.
Publicado: (2018)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

A novel nomogram based on GD for predicting prognosis in hepatocellular carcinoma
por: Liu, Ying, et al.
Publicado: (2023)

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients
por: Jia, Bin, et al.
Publicado: (2023)

A Co-Expression Network Reveals the Potential Regulatory Mechanism of lncRNAs in Relapsed Hepatocellular Carcinoma
por: Fang, Yuan, et al.
Publicado: (2021)

The connection between innervation and metabolic rearrangements in pancreatic cancer through serine
por: Dong, Mengmeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7d2ls7239fethb2sc19aj71lv